|
|
||||
|
Pharmacogenomics Lurches Forward
Small battles push toward making personalized medicine a reality
The Scientist 2004, 18(15):26
|
||||
|
|
||||
|
Medicinal drugs save patients, but compounds fail in many cases and even cause death in others. According to the US Food & Drug Administration's Center for Education and Research on Therapeutics, adverse drug reactions kill 100,000 Americans each year, registering as the fourth leading cause of death.[1]
In the United States at least, prescribed drugs are more lethal than AIDS or automobile accidents. The problem is, no physician can know for certain how a patient will respond to a drug. Pharmacogenomics, however, could help alleviate that problem.
|
(continued >>)
To continue reading this full article, you must be a subscriber to The Scientist.
You are only a few minutes away from unlimited access.
Subscribe to The Scientist to get unlimited access to our premium content
Get unlimited access to this article and over 20 years of The Scientist archives. You won’t miss a word – all for as little as $4.95. Subscribe now.The Scientist offers site licenses to institutions and organizations. Recommend us to your librarian and get online access through your place or work or study.